Phase I study of bortezomib in refractory or relapsed acute leukemias.

Source:http://linkedlifedata.com/resource/pubmed/id/15161691

Clin. Cancer Res. 2004 May 15 10 10 3371-6

Download in:

View as

Triples

General Info

PMID
15161691